Endpoints News – Biotech and pharma business news, with a focus …
Biotech and pharma business news, with a focus on the science, people and money that drive the industry.
Endpoints AI coverage: Come hear from two Nobel winners at our …
2 days ago · In the coming weeks, two of those three Nobel winners are appearing with Dunn on stage at Endpoints events: David Baker of the Institute for Protein Design at the Univer ...
J&J’s medtech slump continues, improvements not expected until …
1 day ago · Sr. Manager/Associate Director, Document Control. Viridian Therapeutics. Waltham, MA, USA. view job offer post your job now. Johnson & Johnson beat investors’ expectations despite its medtech ...
The most ambitious biotechs swinging for the fences in 2023
We’re back with another look at eleven of the most promising biotechs in the global industry. You can expect to see some great science, outstanding leadership and backers that are prepared to go the distance in one of the riskiest endeavors on the planet.
Endpoints 11 - Biopharma's Most Promising Startups in 2021
Sep 22, 2024 · The biotech 2.0 era has arrived. And with that backdrop, we'll unveil the top 11 companies supercharging a new generation of startups in 2021. Watch John Carroll & John Chiminski as they talk biotech with the teams behind the winning companies and learn what defines the Endpoints 11.
Endpoints News — Breaking: FDA issues landmark double …
Dec 8, 2023 · by Ryan Cross: In a 2008 issue of Science, just a page apart, were the two crucial discoveries that would form the cure for sickle cell disease.. Stuart Orkin, a hematologist at Boston Children’s Hospital, had published work identifying the genetic switch that could turn on backup copies of life-sustaining hemoglobin proteins in sick ...
Endpoints at #ASCO24
Jun 4, 2024 · Endpoints at #ASCO24. Tuesday, June 4, 2024. 11:00 AM - 1:40 PM. Each year, the oncology world looks to the ASCO meeting to make sense of the clinical cancer landscape. Data coming out of the meeting will signal pipeline strengths and weaknesses, and point to the next directions for cancer treatment. We’ll cover the biggest news out of the ...
ESMO23 | Cancer breakthroughs and barriers in oncology R&D
After a decade of patient breakthroughs leveraging technologies like immunotherapy, ADCs and targeted therapies, cancer R&D is staring down its next era. Our expert panel will look at how the R&D landscape has shifted, new attempts to go after cancer's “undruggable” targets and how the field is thinking about where the goalposts are in what ...
Endpoints News — Pfizer takes pivotal RSV vaccine data to the …
by Zachary Brennan: The 50-year race to develop an RSV vaccine turned a corner on Thursday with Pfizer unveiling promising pivotal data for its bivalent RSV vaccine candidate, promising to take the data to the FDA ahead of several rivals in a …
Cycle makes another offer for Vanda; Ocean Biomedical, Molecure …
1 day ago · Cycle makes another offer for Vanda; Ocean Biomedical, Molecure ink new deal. October 15, 2024 10:44 AM EDT. News Briefing. Cycle makes another offer for Vanda; Ocean Biomedical, Mol ...